Shieva Ghofrany
Obstetrics & Gynecology · Stamford, CTNPI 1538267356
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by BD at 38.3% of the total. Reporting peaked in 2024 at $15,261 and has fallen 67.1% since, to $5,020 in 2025. Among obstetrics & gynecology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $199.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$13K
- Coopersurgical, Inc.$10K
- AbbVie$6K
- Therapeuticsmd, Inc.$1K
- Hologic Sales And Service, LLC$1K
- Aspira Women's Health Inc$395
- plus $1K from 23 others
What the payments were for
- Consulting fees$17,68654%
- Speaking & faculty fees$10,22531%
- Travel & lodging$2,1016%
- Food & beverage$2,9689%
- Education$730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 10 | $12,645 |
| Coopersurgical, Inc. | 16 | $10,085 |
| AbbVie | 38 | $6,092 |
| Therapeuticsmd, Inc. | 21 | $1,490 |
| Hologic Sales And Service, LLC | 1 | $1,000 |
| Aspira Women's Health Inc | 4 | $395 |
| Avion Pharmaceuticals | 21 | $246 |
| Astellas Pharma US Inc | 4 | $162 |
| Biogen | 4 | $88 |
| Pfizer | 5 | $78 |
| Exact Sciences | 3 | $73 |
| AMAG Pharmaceuticals, Inc. | 4 | $73 |
| Mayne Pharma Commercial LLC | 3 | $70 |
| Agile Therapeutics, Inc. | 3 | $65 |
| Lupin Inc. | 3 | $61 |
| Bayer | 3 | $59 |
| Duchesnay USA Incorporated | 3 | $51 |
| Medicem Inc. | 3 | $43 |
| Millicent US Inc | 2 | $40 |
| Exeltis, USA Inc. | 3 | $40 |
| Myovant Sciences Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Mylan Pharmaceuticals Inc. | 2 | $32 |
| Meditrina | 1 | $19 |
| Mission Pharmacal Company | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Merck | 1 | $12 |
| Organon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elahere$5,430
- Paragard$4,275
- Equipment$2,025
- SOS$1,800
- ANNOVERA$1,200
- Summit Doppler$1,125
- Obstetrical Products$675
- OVA1$278
- Veozah$125
- BIJUVA$120
- BD ONCLARITY$109
How this compares
$33,053 in reported general payments places this provider in the 95th percentile of 605 obstetrics & gynecology providers in Connecticut.
Other obstetrics & gynecology in Stamford
- Sarp AkselStamford$22K
- Daniel CibulskyStamford$17K
- Patrick CahillStamford$8K
- Gary BesserStamford$8K
- George HeadingStamford$8K
- Astrid Hoffmann-OlsenStamford$7K
- Robert GennaroStamford$7K
- David WeinsteinStamford$6K
- Stephanie GoldpinStamford$6K
- Artonius PanagiotakisStamford$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.